Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

US label update for AstraZeneca/B-MS' Onglyza for renally-impaired diabetics - The Pharma Letter PDF Print

US label update for AstraZeneca/B-MS' Onglyza for renally-impaired diabetics
The Pharma Letter
The renal study investigated the safety and efficacy of Onglyza in patients with moderate to severe renal impairment or end-stage renal disease (ESRD). Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

and more »

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.